Blanket Purchase Agreement HT001425AE005
- Not listed
- This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Becton, Dickinson and Company (BD) for the provision of diagnostic testing equipment, supplies, and reagents. The single-award BPA has a ceiling value of $7,000,000 and a period of performance extending through April 2030. As a prime contractor, BD will deliver a wide range of specialized medical diagnostic technologies and supporting services to the DHA, including blood culture systems, microbiology...
- The Defense Health Agency awarded a single-award Blanket Purchase Agreement valued at $249,000 to Becton, Dickinson Italia S.P.A., a subsidiary of Becton, Dickinson and Company, effective March 1, 2024 through February 28, 2029. The BPA covers microbiological and bacteriological culture products compatible with the BD MAX automated platform, a diagnostic testing system used in military medical facilities. No small business set-aside was applied to this award. Performance of the contract occurs...
- The Defense Health Agency awarded a blanket purchase agreement to Qiagen, LLC for reagents, consumables, and related laboratory supplies. The single award BPA has a potential value of $8 million and a period of performance through February 2025. Two firm fixed price call contracts were subsequently awarded against the BPA, the first for $60,041 worth of reagents and peripherals consumables to be delivered to Bethesda, Maryland by September 2021. The second call contract was for $125,000 of...
- This Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 to Becton, Dickinson and Company (BD) is for the provision of DiaSorin MYCOBACTERIUM MIGIT reagents and supplies. The total ceiling value of the BPA is $138,963.45, with multiple task orders issued under it ranging from $27,605.42 to $138,568.87. The contract supports the VA's efforts to ensure the availability of critical medical laboratory supplies and reagents...
- The Defense Health Agency has awarded a single-award Blanket Purchase Agreement (BPA) contract to Polyscientific Research and Development Corporation, a leading manufacturer of chemicals, stains, and reagents for in vitro diagnostic testing. The $8 million BPA contract, with a period of performance through September 2026, provides the agency with an efficient mechanism to procure a wide range of reagents and consumable supplies to support its medical testing and research programs. Specific...
- This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) to Becton, Dickinson and Company (BD), a global medical technology manufacturer. The contract has a ceiling value of $749,000.00 and runs through July 31, 2030. Under this single-award BPA, BD will provide the VA with a range of critical medical diagnostic equipment, supplies, and services, including blood culture testing, microbiology analyzers, and related reagents and consumables. The contract was...
- The Defense Logistics Agency Troop Support Medical has awarded Becton, Dickinson and Company (BD), a leading medical technology manufacturer, an Indefinite Delivery Contract valued at $3,502,725 to provide medical supplies, diagnostic equipment, and related products. The contract has a period of performance through August 2024. Under this agreement, BD Diagnostic Systems, a division of BD, is the prime contractor responsible for delivering a range of items to support the agency's medical...
- This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 to Becton, Dickinson and Company (BD), operating through its BD Biosciences division. The $1,238,028.93 contract provides flowcytometry reagents and maintenance services to support VA healthcare facilities in the VISN 19 region through December 31, 2024. The BPA is a single-award vehicle that enables simplified ordering of specialized...
- The Defense Health Agency awarded a single-award Blanket Purchase Agreement (BPA) valued at $6.0 million to Fisher Scientific Company L.L.C. (operating as Fisher Healthcare) on May 8, 2025, with an ultimate completion date of May 7, 2030. This indefinite delivery vehicle procures microbiology media, specimen collection supplies, and related microbiology medical supplies and reagents to support the Defense Health Agency's laboratory and diagnostic testing operations across its healthcare delivery...
- Becton, Dickinson and Company (BD), through its Infectious Diseases Systems division operating as BD Diagnostic Systems, holds a multiple-award Federal Supply Schedule contract under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule. The contract was awarded on May 1, 2014, with an ultimate completion date of April 30, 2026, and carries a ceiling value of $52,500,000. The contract was awarded on a full and open competitive basis without set-aside...
The Defense Health Agency awarded a single-award Blanket Purchase Agreement valued at $4.0 million to Becton, Dickinson and Company (BD Biosciences) on September 15, 2025, for the procurement of reagents with an ultimate completion date of September 14, 2030. This BPA establishes an indefinite delivery vehicle enabling the Defense Health Agency to streamline and expedite the acquisition of specialized laboratory reagents from the prime contractor without requiring competitive re-solicitation for individual orders. No small business set-aside was applied to this procurement, reflecting the specialized and proprietary nature of the products being acquired. The contract structure allows the Defense Health Agency to place task orders against the established ceiling value throughout the five-year performance period, providing flexible procurement of reagent supplies required to support military healthcare operations and medical research initiatives across the Department of Defense. As a leading global medical technology manufacturer, Becton, Dickinson and Company, through its BDB Division operating as BD Biosciences, supplies sophisticated laboratory reagents and consumables that support advanced diagnostic and research capabilities. Based on BD's existing federal contract portfolio and documented expertise, the reagents procured under this BPA likely support flow cytometry systems, cell imaging technologies, and biomedical research applications critical to Defense Health Agency operations. The company's established track record with the Department of Veterans Affairs, National Institutes of Health, and other federal agencies demonstrates its capacity to reliably supply specialized reagent kits, antibodies, and associated consumables that enable complex laboratory analyses and clinical diagnostics. This BPA consolidates Defense Health Agency's reagent procurement under a single qualified vendor, reducing administrative burden while ensuring consistent access to high-quality products essential for military medical research and healthcare delivery missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/15/25 |